TRIGLYCERIDE-RICH LIPOPROTEINS IMPROVE SURVIVAL WHEN GIVEN AFTER ENDOTOXIN IN RATS

被引:48
作者
READ, TE
GRUNFELD, C
KUMWENDA, Z
CALHOUN, MC
KANE, JP
FEINGOLD, KR
RAPP, JH
机构
[1] VET AFFAIRS MED CTR, SURG SERV 112, SAN FRANCISCO, CA 94121 USA
[2] VET AFFAIRS MED CTR, METAB SECT, SAN FRANCISCO, CA 94121 USA
[3] UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA USA
[4] UNIV CALIF SAN FRANCISCO, CARDIOVASC RES INST, DEPT SURG, SAN FRANCISCO, CA USA
关键词
D O I
10.1016/S0039-6060(05)80231-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Triglyceride-rich lipoproteins have been shown to bind bacterial endotoxin and inhibit its activity in vitro and to protect animals from death when administered before a lethal injection of endotoxin. We now demonstrate that triglyceride-rich lipoproteins can neutralize the toxic effects of endotoxin already in circulation. Methods. Rats were infused with a lethal dose of endotoxin, followed al various lime intervals by an infusion of either mesenteric lymph containing nascent chylomicrons (1 gm chylomicron triglyceride/kg) or an equal volume of normal saline solution. Survival was measured al 48 hours. The experiment teas then repeated, substituting the synthetic triglyceride-rich lipid emulsion (1 gm/kg) for chylomicrons. rile also measured the clearance and tissue distribution of radioiodinated endotoxin in rats treated subsequently with chylomicrons or saline solution. Results. Chylomicron infusions significantly improved survival when given up to 30 minutes after a lethal dose of endotoxin (p < 0.05). Chylomicrons accelerated endotoxin clearance from the blood and increased endotoxin uptake by the liver. The synthetic triglyceride-rich lipid emulsion significantly improved survival when given up to 15 minutes after a lethal close of endotoxin (p < 0.05). Conclusions. Triglyceride-rich lipoproteins and synthetic triglyceride-rich lipid emulsions significantly improve survival of rats when given after a lethal dose of endotoxin. Lipoprotein treatment accelerates endotoxin clearance to the liver, which may account for the observed protection. These data suggest a possible therapeutic role for triglyceride-rich lipoproteins or synthetic lipid emulsions in the treatment of the endotoxemia of gram-negative sepsis.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 37 条
[1]  
ANDERSON BO, 1991, SURG GYNECOL OBSTET, V172, P415
[2]   LIPID-METABOLISM IN INFECTION [J].
BLACKBURN, GL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1977, 30 (08) :1321-1332
[3]  
CABANA VG, 1989, J LIPID RES, V30, P39
[4]   PHYSIOLOGIC CONCENTRATIONS OF NORMAL HUMAN-PLASMA LIPOPROTEINS INHIBIT THE IMMORTALIZATION OF PERIPHERAL LYMPHOCYTES-B BY THE EPSTEIN-BARR VIRUS [J].
CHISARI, FV ;
CURTISS, LK ;
JENSEN, FC .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (02) :329-336
[5]   CYTOKINE SERUM LEVEL DURING SEVERE SEPSIS IN HUMAN IL-6 AS A MARKER OF SEVERITY [J].
DAMAS, P ;
LEDOUX, D ;
NYS, M ;
VRINDTS, Y ;
DEGROOTE, D ;
FRANCHIMONT, P ;
LAMY, M .
ANNALS OF SURGERY, 1992, 215 (04) :356-362
[6]   PATTERNS OF CYTOKINES, PLASMA ENDOTOXIN, PLASMINOGEN-ACTIVATOR INHIBITOR, AND ACUTE-PHASE PROTEINS DURING THE TREATMENT OF SEVERE SEPSIS IN HUMANS [J].
DOFFERHOFF, ASM ;
BOM, VJJ ;
DEVRIESHOSPERS, HG ;
VANINGEN, J ;
VANDERMEER, J ;
HAZENBERG, BPC ;
MULDER, POM ;
WEITS, J .
CRITICAL CARE MEDICINE, 1992, 20 (02) :185-192
[7]   CHYLOMICRONS CAN INHIBIT ENDOTOXIN ACTIVITY INVITRO [J].
EICHBAUM, EB ;
HARRIS, HW ;
KANE, JP ;
RAPP, JH .
JOURNAL OF SURGICAL RESEARCH, 1991, 51 (05) :413-416
[8]   INVITRO INACTIVATION OF BACTERIAL-ENDOTOXIN BY HUMAN LIPOPROTEINS AND APOLIPOPROTEINS [J].
EMANCIPATOR, K ;
CSAKO, G ;
ELIN, RJ .
INFECTION AND IMMUNITY, 1992, 60 (02) :596-601
[9]  
FEINGOLD KR, 1992, J LIPID RES, V33, P1765
[10]   FAT EMULSION FOR INTRAVENOUS ADMINISTRATION - CLINICAL EXPERIENCE WITH INTRALIPID 10PERCENT [J].
HANSEN, LM ;
HARDIE, WR ;
HIDALGO, J .
ANNALS OF SURGERY, 1976, 184 (01) :80-88